id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0047-0003,FDA,FDA-2002-P-0047,FDA/CDER to Lavender Consulting Services,Other,PAV-Petition Approval,2002-09-27T04:00:00Z,2002,9,,,2008-04-12T01:26:07Z,,0,0,090000648048b830
FDA-2002-P-0047-0002,FDA,FDA-2002-P-0047,"FDA/DDM to Lavender Consulting Services, Inc",Other,ACK-Acknowledgement Letter,2002-04-11T04:00:00Z,2002,4,,,2008-04-12T01:26:07Z,,0,0,090000648048b82f
FDA-2002-P-0047-0001,FDA,FDA-2002-P-0047,"FDA/DDM to Lavender Consulting Services, Inc",Other,ACK-Acknowledgement Letter,2002-04-11T04:00:00Z,2002,4,,,2008-04-12T01:26:07Z,,0,0,090000648048b828